Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Supriti Samantaray

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Neuroscience Letters|July 10, 2003
Calcium channel agonist, (+/-)-Bay K8644, causes an immediate increase in the striatal 1-methyl-4-phenylpyridinium level following systemic administration of the dopaminergic neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in Balb/c miceSupriti Samantaray, Kochupurackal P Mohanakumar
Neuroscience Letters|May 3, 2003
Calcium channel agonist, (+/-)-Bay K8644, causes a transient increase in striatal monoamine oxidase activity in Balb/c miceSupriti Samantaray, Goutam Chandra, Kochupurackal P Mohanakumar
Synapse (New York, N.Y.)|July 23, 2003
D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicityDhanasekharan Muralikrishnan, Supriti Samantaray, Kochupurackal P Mohanakumar
CNS & Neurological Disorders Drug Targets|August 5, 2008
Calpain as a potential therapeutic target in Parkinson's diseaseSupriti Samantaray, Swapan K Ray, Naren L Banik
Neural Regeneration Research|April 13, 2017
Correction: Future directions for using estrogen receptor agonists in the treatment of acute and chronic spinal cord injurySwapan K Ray, Supriti Samantaray, Naren L Banik
Annals of the New York Academy of Sciences|July 17, 2010
Physiological low dose of estrogen-protected neurons in experimental spinal cord injurySupriti Samantaray, Denise D Matzelle, Swapan K Ray, et al.
Journal of Neurochemistry|July 24, 2013
Critical role of calpain in spinal cord degeneration in Parkinson's diseaseSupriti Samantaray, Varduhi H Knaryan, Donald C Shields, et al.
Neurochemistry International|July 11, 2016
Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in miceAlpana Singh, Poonam Verma, Gillela Balaji, et al.
Neuroscience Letters|February 8, 2005
A synthetic human proline-rich-polypeptide enhances hydroxyl radical generation and fails to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced toxicity in miceVarduhi H Knaryan, Supriti Samantaray, Armen A Galoyan, et al.
Annals of the New York Academy of Sciences|November 16, 2006
Calpain activation in apoptosis of motoneurons in cell culture models of experimental parkinsonismSupriti Samantaray, Swapan K Ray, Syed F Ali, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Neuroscience Letters|July 10, 2003
Calcium channel agonist, (+/-)-Bay K8644, causes an immediate increase in the striatal 1-methyl-4-phenylpyridinium level following systemic administration of the dopaminergic neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in Balb/c miceSupriti Samantaray, Kochupurackal P Mohanakumar
Neuroscience Letters|May 3, 2003
Calcium channel agonist, (+/-)-Bay K8644, causes a transient increase in striatal monoamine oxidase activity in Balb/c miceSupriti Samantaray, Goutam Chandra, Kochupurackal P Mohanakumar
Synapse (New York, N.Y.)|July 23, 2003
D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicityDhanasekharan Muralikrishnan, Supriti Samantaray, Kochupurackal P Mohanakumar
CNS & Neurological Disorders Drug Targets|August 5, 2008
Calpain as a potential therapeutic target in Parkinson's diseaseSupriti Samantaray, Swapan K Ray, Naren L Banik
Neural Regeneration Research|April 13, 2017
Correction: Future directions for using estrogen receptor agonists in the treatment of acute and chronic spinal cord injurySwapan K Ray, Supriti Samantaray, Naren L Banik
Annals of the New York Academy of Sciences|July 17, 2010
Physiological low dose of estrogen-protected neurons in experimental spinal cord injurySupriti Samantaray, Denise D Matzelle, Swapan K Ray, et al.
Journal of Neurochemistry|July 24, 2013
Critical role of calpain in spinal cord degeneration in Parkinson's diseaseSupriti Samantaray, Varduhi H Knaryan, Donald C Shields, et al.
Neurochemistry International|July 11, 2016
Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in miceAlpana Singh, Poonam Verma, Gillela Balaji, et al.
Neuroscience Letters|February 8, 2005
A synthetic human proline-rich-polypeptide enhances hydroxyl radical generation and fails to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced toxicity in miceVarduhi H Knaryan, Supriti Samantaray, Armen A Galoyan, et al.
Annals of the New York Academy of Sciences|November 16, 2006
Calpain activation in apoptosis of motoneurons in cell culture models of experimental parkinsonismSupriti Samantaray, Swapan K Ray, Syed F Ali, et al.
Pageof 4